Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01HPY
|
||||
| Former ID |
DIB001541
|
||||
| Drug Name |
Melphalan flufenamide
|
||||
| Synonyms |
J-1; Dipeptide-conjugated melphalan prodrug (iv formulation, ovary tumor), Oncopeptides
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Ovarian cancer [ICD9: 183; ICD10:C56] | Phase 1/2 | [1] | ||
| Company |
Oncopeptides AB
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C24H30Cl2FN3O3
|
||||
| Canonical SMILES |
c1c(ccc(c1)N(CCCl)CCCl)C[C@H](N)C(=O)N[C@H](C(=O)OCC)Cc<br />1ccc(cc1)F
|
||||
| CAS Number |
CAS 380449-51-4
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | Binder | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033866) | ||||
| REF 2 | National Cancer Institute Drug Dictionary (drug id 751473). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.